Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase Ib/II, Multicenter, Open-Label Study to Evaluate Safety, Efficacy, and Pharmacokinetics of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

This is a phase Ib/II, multicenter, open-label study of YL201 combined with atezolizumab. The study will include 2 parts. Part 1 of the study is a dose escalat…

Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma

MediLink Therapeutics (Suzhou) Co., Ltd.NCT07407933